Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Weiang Yan"'
Autor:
Keshav Narayan Alagarsamy, Sajitha Mathan, Weiang Yan, Alireza Rafieerad, Saravanan Sekaran, Hanna Manego, Sanjiv Dhingra
Publikováno v:
Bioactive Materials, Vol 6, Iss 8, Pp 2261-2280 (2021)
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Heart attack and stroke cause irreversible tissue damage. The currently available treatment options are limited to “damage-control” rather than tissue repair. The recent adv
Externí odkaz:
https://doaj.org/article/446393196fdd46a7862122cf6d605abb
Autor:
Christopher J. Parr, MD, Weiang Yan, MD, Olga Toleva, MD, John Ducas, MD, Philip J. Garber, MD
Publikováno v:
CJC Open, Vol 2, Iss 2, Pp 71-73 (2020)
A 78-year-old woman presented with an inferior ST-segment elevation myocardial infarction in the setting of a fall resulting in facial trauma causing an unrecognized C6 cervical endplate fracture. After administration of tenecteplase, she developed a
Externí odkaz:
https://doaj.org/article/a21f5e0cdcb24a54944e2346a95ad9c0
Publikováno v:
Materials & Design, Vol 196, Iss , Pp 109091- (2020)
Next-generation “early transition metal carbides and nitrides” (MXene) materials have facile and economic processing with simultaneous synthesis and functionalization. Their surface characteristics can be tailored for specific applications, inclu
Externí odkaz:
https://doaj.org/article/e48e759753ec40c696f5a7e777f9b71c
Publikováno v:
Current Opinion in Cardiology. 37:459-467
The recent American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions Guidelines for Coronary Artery Revascularization have raised concerns on the survival benefits of coronary artery bypass gra
Autor:
Ricky Muller Moran, Rachel Eikelboom, Michael J. Reardon, Michael H. Yamashita, Weiang Yan, Apurva Patel, Aaron Spooner
Publikováno v:
Current Opinion in Cardiology. 37:173-179
Purpose of review This review analyzes currently available commercial transcatheter aortic valve replacement (TAVR) valves as well as valves in investigational status and those in preclinical testing. The design features and clinical outcomes of the
Autor:
Sajitha Mathan, Alireza Rafieerad, Weiang Yan, Hanna Manego, Saravanan Sekaran, Sanjiv Dhingra, Keshav Narayan Alagarsamy
Publikováno v:
Bioactive Materials, Vol 6, Iss 8, Pp 2261-2280 (2021)
Bioactive Materials
Bioactive Materials
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Heart attack and stroke cause irreversible tissue damage. The currently available treatment options are limited to “damage-control” rather than tissue repair. The recent adv
Autor:
Michael H. Yamashita, Weiang Yan
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 165:580-581
Publikováno v:
Circulation Research. 131
Transplant vasculopathy is an aggressive form of atherosclerosis that manifests uniquely in transplanted hearts, lungs, and kidneys. Recently, immunoengineered transition metal carbides, or MXenes, have demonstrated unique immunomodulatory properties
Autor:
Glen Lester Sequiera, Abhay Srivastava, Niketa Sareen, Weiang Yan, Keshav Narayan Alagarsamy, Elika Verma, Mohamad Reza Aghanoori, Michel Aliani, Ashok Kumar, Paul Fernyhough, Cheryl Rockman-Greenberg, Sanjiv Dhingra
Publikováno v:
Science Advances. 8
A “Leap-of-Faith” approach is used to treat patients with previously unknown ultrarare pathogenic mutations, often based on evidence from patients having dissimilar but more prevalent mutations. This uncertainty reflects the need to develop perso
Autor:
Ejlal Abu-El-Rub, Sanjiv Dhingra, Asmaa Mohammed ShamsEldeen, Glen Lester Sequiera, Hania Ibrahim Ammar, Niketa Sareen, Meenal Moudgil, Ilan Rubinchik, Weiang Yan, Laila A. Rashed, Heba S. Shokry
Publikováno v:
The FASEB Journal. 34:12860-12876
Allogeneic mesenchymal stem cells (MSCs) from young and healthy donors are immunoprivileged and have the potential to treat numerous degenerative diseases. However, recent reviews of clinical trials report poor long-term survival of transplanted cell